Complication rates were also considered, including seroma, infection, expander/implant explantation, removal of mesh, and capsular contracture. Statistical analysis was performed utilizing Fisher exact test and chi-squared test for categorical variables and Mann-Whitney U test for continuous variables. Time to 2 nd stage, number of expansions, and relative initial fill volumes showed no statistical difference between the ADM and Gore DualMesh groups (p=0.539, 0.146 and 0.494 respectively). Furthermore, the Gore DualMesh group underwent significantly fewer fills (p<0.001) and had a higher relative initial fill volume (p<0.001) compared to total muscle coverage. The additional cost per breast as a result of including DualMesh was on average $385 versus $4287 for ADM. Complication rates were similar between all three groups without statistically significant differences.
in plastic surgery and the accuracy of the publically available Open Physician Payment (OPP) Sunshine Act database.
METHODS:
We analyzed all scientific articles published in four plastic surgery journals from September 2013 to January 2014. The COI disclosure statement of all these articles was reviewed and the full name and affiliation of all the investigators, regardless of whether or not he/she disclosed a COI, was recorded. All investigators were searched in the OPP database to determine whether a financial transaction was reported by industry during the study period. To further examine the factors associated with disclosure of COI in the plastic surgery literature, a multivariable regression analysis was performed.
RESULTS:
A total of 1002 investigators published scientific articles during the study period. Of these, only 90 (9%) investigators disclosed a COI. In contrast, a total of 428 (42.7%) investigators were found to have received payments/gifts from industry according to the OPP database. The overall rate of disclosure was 36.0% (68 out of 189). In the multivariate analysis, investigators that were non-academic, received payments exceeding $500, and published scientific articles related to the sponsoring-biomedical company were more likely to disclose COI (p < 0.0001).
CONCLUSION:
The incidence of industry payments reported in the OPP database greatly exceeded the rate of self-reported COI by plastic surgeons. Our analysis suggests that there exist major discrepancies between self-reported COI as disclosed by investigators and the industry-mandated OPP database.
